Anti-CD79b Antibody (Polatuzumab)
Catalog No.
F1637
Anti-CD79b Antibody (Polatuzumab)
Featured Products
Polatuzumab is a monoclonal antibody with a chemotherapeutic active molecule. Polatuzumab targets CD79b, which is present on the surface of B cells. Polatuzumab attaches to the CD79b protein and delivers the chemotherapeutic active molecule into the cell. The active molecule then kills the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin. Polatuzumab Vedotin is an antibody-active molecule conjugate (ADC) for CD79b.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.26 kDa
Dry ice
2279068-37-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
polatuzumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P40259
Human, Mouse, Rat, Pig, Macaque, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD79b His at 16 ug/mL can bind Anti-CD79b Antibody (Polatuzumab)
CD79b
Please avoid freeze-thaw cycles.